comparemela.com

Latest Breaking News On - Teresa brophy bair - Page 2 : comparemela.com

Kura Oncology (NASDAQ:KURA) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research note published on Monday, Benzinga reports. HC Wainwright currently has a $32.00 target price on the stock. Several other research firms have also weighed in on KURA. StockNews.com lowered Kura Oncology from a hold rating to a […]

China
Kathleen-ford
Teresa-brophy-bair
China-universal-asset-management-co
E-fund-management-co
Securities-exchange-commission
Kura-oncology-inc
Fund-management-co
Kura-oncology
Free-report
Moderate-buy
Get-free-report

Kura Oncology, Inc. (NASDAQ:KURA) Receives Average Recommendation of "Moderate Buy" from Analysts

Kura Oncology, Inc. (NASDAQ:KURA) Receives Average Recommendation of "Moderate Buy" from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
Teresa-brophy-bair
Troy-edward-wilson
Kura-oncology-company-profile
Tower-research-capital
Securities-exchange-commission
Us-bancorp
Royal-bank
Nasdaq
Kura-oncology-inc
Kura-oncology

Citigroup Inc. Acquires 22,357 Shares of Kura Oncology, Inc. (NASDAQ:KURA)

Citigroup Inc. increased its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 29.3% during the 3rd quarter, HoldingsChannel reports. The firm owned 98,557 shares of the company’s stock after purchasing an additional 22,357 shares during the period. Citigroup Inc.’s holdings in Kura Oncology were worth $899,000 as of its most recent […]

United-states
Mizuho
Sakhalinskaya-oblast
Russia
Teresa-brophy-bair
Kathleen-ford
Group-plc
Nasdaq
Securities-exchange-commission
Metlife-investment-management
Guggenheim-capital
Kura-oncology-company-profile

HC Wainwright Comments on Kura Oncology, Inc.'s Q1 2024 Earnings (NASDAQ:KURA)

Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – Research analysts at HC Wainwright issued their Q1 2024 earnings per share estimates for shares of Kura Oncology in a research report issued to clients and investors on Wednesday, February 28th. HC Wainwright analyst J. Pantginis expects that the company will post earnings per share of ($0.58) […]

United-states
Teresa-brophy-bair
Troy-edward-wilson
Kura-oncology-inc
Group-plc
Nasdaq
Guggenheim-capital
Securities-exchange-commission
Us-bancorp
Metlife-investment-management
Kura-oncology-company-profile
Manufacturers-life-insurance-company

Deerfield Management Company L.P. Series C Boosts Stock Position in Kura Oncology, Inc. (NASDAQ:KURA)

Deerfield Management Company L.P. Series C lifted its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 35.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,374,044 shares of the company’s stock after buying an additional […]

United-states
Kathleen-ford
Teresa-brophy-bair
Dimensional-fund-advisors
Raymond-james-associates
Metlife-investment-management
Bridgefront-capital
Deerfield-management-companylp-series
Kura-oncology-inc
Nasdaq
Exchange-commission
Vanguard-group-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.